Business Insights – The Pharmaceutical Market Outlook to 2018

Description

The Pharmaceutical Market Outlook to 2018

By: Dr. Sarah Riley

Key threats and opportunities for Big Pharma and its responses to them

“Total pharma R&D spend has been increasing by 15% per annum to reach $70bn in 2007, and is forecast to reach $85bn in 2009. Similarly, biotech R&D spend reached $13bn in 2007…”

The pharma industry must respond to a number of key challenges over the next ten years in order to sustain recent levels of growth. Recent strategies have seen a rise in outsourcing and the restructuring of R&D processes. Turbulence in the global economy is also having a significant impact upon the biotech industry, where externally funded companies are particulary vulnerable to investment downturns.

‘The Pharmaceutical Market Outlook to 2018’ is a new report published by Business Insights that explores the key threats and opportunities facing the pharma industry over the next ten years. This report analyses how leading companies including Pfizer, Roche, GSK, and Merck & Co. are optimizing their approaches and growth strategies to succeed in the changing market landscape. The performances of the top 10 pharma companies over the past five years are also assessed and a proprietary Business Insights survey evaluates the views of industry executives as to future market growth, biotech M&A activity, personalised medicine and pipeline activity.

Understand how the pharma market will evolve over the next ten years and compare the strategic responses of leading players with this report…

Use this new report to…

• Discover the key threats and opportunities facing the pharma industry over the next ten years with this report’s detailed evaluation of R&D challenges, increasing generic competition, biotech developments, new technologies and emerging markets.
• Assess the competitive landscape of the global pharma market with this report’s analysis of the top 10 pharma companies based on total pharma sales, branded pharma revenues, product/therapy area mixes and a breakdown of leading developmental products.
   
• Compare how leading pharma companies are adapting to the
  evolving pharma market by examining the individual challenges,
  growth strategies, M&A initiatives and pipeline prospects of major
  players including Pfizer, GlaxoSmithKline, Merck & Co. and Roche.
   
• Identify how the global pharma market is likely to change over the next ten years by using this report’s analysis of a Business Insights’ proprietary survey which reveals the opinions and expectations of industry executives in relation to the future pipeline, marketed products, business strategies and alliances.

Digital Download Business Insights – The Pharmaceutical Market Outlook to 2018 at coursegb.com Now!

Sales page:
Archive: https://web.archive.org/web/20101125063840/http://www.globalbusinessinsights.com/content/rbhc0214p.htm